Excellence in Fluorinated Pharmaceutical Intermediates – Baokai Pharma Sets the Benchmark in High-End Fluorochemicals

Share:

Located in the Qidong Life and Health Industrial Park, Jiangsu Province, a technology-driven enterprise that has been dedicated to the field of fluorinated fine chemicals for nearly two decades—Nantong Baokai Pharmaceutical Co., Ltd.—is steadily advancing in the specialized niche of fluorinated pharmaceutical intermediates with its formidable technical capabilities and well-established industrial footprint, emerging as one of the leading forces in this sector in China.

Corporate Profile: Founded in 2006, Deeply Rooted in Fluorinated Pharmaceuticals

Nantong Baokai medical Co., Ltd. was established in 2006, originally operating as Nantong Baokai Chemical Co., Ltd. before officially adopting its current name in 2019. Located in the Qidong Life and Health manufacturing Park, Jiangsu Province, the company occupies 46 mu (approximately 3.07 hectares) with a registered capital of 25 million RMB. It is a national high-tech enterprise integrating research studies, research, production, and sales.

The company has built an "sector-academia-research integrated" R&D system, establishing prolonged and close collaborative relationships with renowned domestic and international universities, including Zhejiang University, Zhejiang University of Science and methodology, and the University of Emden-Leer in Germany. All of its items are backed by independent intellectual property rights. The company has obtained ISO 9001 condition regulation System, ISO 14000 Environmental regulation System, and ISO 45001 Occupational Health and security regulation System certifications, and has passed the provincial security standardization compliance assessment. In recent years, the company has been honored with multiple awards, including "National High-Tech Enterprise," "Jiangsu Provincial Specialized and Sophisticated SME," "Jiangsu Provincial Service-Oriented Manufacturing Demonstration Enterprise," and "Qidong Top 100 manufacturing Enterprise."

Previous

Ineos and Recuro plan to build a plastic recycling facility in Norway.

Next

450,000 tons of polypropylene! The first new unit to start trial operation in 2026, with full production capacity reached by mid-month.

Quick inquiry

Create

Inquiry Sent

We will contact you soon